- Home
- Publications
- Publication Search
- Publication Details
Title
Immunotherapy for colorectal cancer: where are we heading?
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 17, Issue 6, Pages 709-721
Publisher
Informa UK Limited
Online
2017-04-05
DOI
10.1080/14712598.2017.1315405
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization
- (2017) Silvia Pesce et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Antitumor Activity of Cytotoxic Cyclooxygenase-2 Inhibitors
- (2016) Md. Jashim Uddin et al. ACS Chemical Biology
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Diverse macrophages polarization in tumor microenvironment
- (2016) Inmoo Rhee ARCHIVES OF PHARMACAL RESEARCH
- Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers
- (2016) Jung Ho Kim et al. BRITISH JOURNAL OF CANCER
- Oncolytic Virus-Mediated Targeting of PGE 2 in the Tumor Alters the Immune Status and Sensitizes Established and Resistant Tumors to Immunotherapy
- (2016) Weizhou Hou et al. CANCER CELL
- The Multifaceted Role of Perivascular Macrophages in Tumors
- (2016) Claire E. Lewis et al. CANCER CELL
- Macrophages induce resistance to 5-fluorouracil chemotherapy in colorectal cancer through the release of putrescine
- (2016) Xuan Zhang et al. CANCER LETTERS
- Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen
- (2016) Emeric Limagne et al. CANCER RESEARCH
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy
- (2016) Etienne Becht et al. CLINICAL CANCER RESEARCH
- The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy
- (2016) James W.T. Toh et al. Clinical Colorectal Cancer
- Review Article
- (2016) Shuji Ogino et al. EPIDEMIOLOGY
- Global patterns and trends in colorectal cancer incidence and mortality
- (2016) Melina Arnold et al. GUT
- Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
- (2016) Bernhard Mlecnik et al. IMMUNITY
- Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial
- (2016) F Stephen Hodi et al. LANCET ONCOLOGY
- Clinicopathologic profile, immunophenotype and genotype of CD274 (PD-L1)-positive colorectal carcinomas
- (2016) Shingo Inaguma et al. MODERN PATHOLOGY
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis
- (2016) Bernhard Mlecnik et al. Science Translational Medicine
- The Role of Prostaglandin E 2 in Tumor-Associated Immunosuppression
- (2016) Dingzhi Wang et al. TRENDS IN MOLECULAR MEDICINE
- Immunotherapy in human colorectal cancer: Challenges and prospective
- (2016) Xuan Sun et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer
- (2016) Byungho Lim WORLD JOURNAL OF GASTROENTEROLOGY
- Cancer-Associated Immune Resistance and Evasion of Immune Surveillance in Colorectal Cancer
- (2016) Pietro Parcesepe et al. Gastroenterology Research and Practice
- Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma
- (2016) Marios Giannakis et al. Cell Reports
- Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer
- (2016) Cong-Min Zhang et al. International Journal of Environmental Research and Public Health
- Progress in the clinical detection of heterogeneity in breast cancer
- (2016) Jun-Long Song et al. Cancer Medicine
- Cell Type-Specific Regulation of Immunological Synapse Dynamics by B7 Ligand Recognition
- (2016) Joanna Brzostek et al. Frontiers in Immunology
- Reducing prostaglandin E2production to raise cancer immunogenicity
- (2016) Santiago Zelenay et al. OncoImmunology
- Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?
- (2015) G O'Callaghan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
- (2015) Santiago Zelenay et al. CELL
- New toxicity profile for novel immunotherapy agents: focus on immune-checkpoint inhibitors
- (2015) C Ciccarese et al. Expert Opinion on Drug Metabolism & Toxicology
- VEGF-A modulates expression of inhibitory checkpoints on CD8+T cells in tumors
- (2015) Thibault Voron et al. JOURNAL OF EXPERIMENTAL MEDICINE
- FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
- (2015) Chiara Cremolini et al. LANCET ONCOLOGY
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Microsatellite Instable Subset of Colorectal Cancer Is a Particularly Good Candidate for Checkpoint Blockade Immunotherapy
- (2015) Yanping Xiao et al. Cancer Discovery
- Mast cell/MDSC a liaison immunosuppressive for tumor microenvironment
- (2015) Luca Danelli et al. OncoImmunology
- Fusobacterium nucleatumand T Cells in Colorectal Carcinoma
- (2015) Kosuke Mima et al. JAMA Oncology
- The predictive value ofKRAS, NRAS, BRAF, PIK3CAand PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis
- (2014) Christina Therkildsen et al. ACTA ONCOLOGICA
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised, double-blind, placebo-controlled trial
- (2014) Hans-Joachim Schmoll et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy
- (2014) Justin D Glenn World Journal of Stem Cells
- Biliary strictures: diagnostic considerations and approach
- (2014) A. Singh et al. Gastroenterology Report
- Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients
- (2013) Mercedes Herrera et al. CANCER SCIENCE
- Immunobiology of mesenchymal stem cells
- (2013) S Ma et al. CELL DEATH AND DIFFERENTIATION
- Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
- (2013) Aleksandar D. Kostic et al. Cell Host & Microbe
- Immune system: a double-edged sword in cancer
- (2013) Bodduluru Lakshmi Narendra et al. INFLAMMATION RESEARCH
- Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention
- (2013) Dora Colussi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
- (2013) Jérôme Galon et al. JOURNAL OF PATHOLOGY
- The Tumor Microenvironment: A Pitch for Multiple Players
- (2013) Giovanna Schiavoni et al. Frontiers in Oncology
- Cancer classification using the Immunoscore: a worldwide task force
- (2012) Jérôme Galon et al. Journal of Translational Medicine
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) Axel Grothey et al. LANCET
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Th17 and Th17-stimulated CD8+ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity
- (2011) Manjunatha Ankathatti Munegowda et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer
- (2011) Sylvain Ladoire et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer immunology—analysis of host and tumor factors for personalized medicine
- (2011) Shuji Ogino et al. Nature Reviews Clinical Oncology
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair
- (2010) Yufang Shi et al. CELL RESEARCH
- Immune Regulation of Cancer
- (2010) Mary L. Disis JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Deficient mismatch repair system in patients with sporadic advanced colorectal cancer
- (2009) M Koopman et al. BRITISH JOURNAL OF CANCER
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor?
- (2009) Maria A. Curotto de Lafaille et al. IMMUNITY
- Immune infiltration in human tumors: a prognostic factor that should not be ignored
- (2009) F Pagès et al. ONCOGENE
- Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
- (2008) Paul Salama et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started